[Form 4] Bausch Health Companies Inc Insider Trading Activity
John Paulson, through managed funds, acquired 34,721,118 shares of Bausch Health Companies Inc. at $9 per share on 08/14/2025, increasing the funds' reported beneficial ownership to 70,755,869 shares. The Form 4 shows the purchase was reported as an indirect holding by the Funds managed by Paulson, and the filing includes a standard disclaimer that Paulson disclaims beneficial ownership except for any pecuniary interest. The transaction reflects a sizable increase in reported stake via managed accounts.
John Paulson, tramite fondi gestiti, ha acquisito 34.721.118 azioni di Bausch Health Companies Inc. a 9$ per azione il 08/14/2025, portando la partecipazione beneficiaria dichiarata dei fondi a 70.755.869 azioni. Il Modulo 4 indica che l'acquisto 猫 stato segnalato come detenzione indiretta dai fondi gestiti da Paulson e la comunicazione include la consueta clausola con cui Paulson declina la titolarit脿 beneficiaria, fatta eccezione per eventuali interessi pecuniari. L'operazione rappresenta un consistente aumento della partecipazione riportata tramite conti gestiti.
John Paulson, a trav茅s de fondos administrados, adquiri贸 34.721.118 acciones de Bausch Health Companies Inc. a 9$ por acci贸n el 08/14/2025, elevando la participaci贸n beneficiaria reportada de los fondos a 70.755.869 acciones. El Formulario 4 muestra que la compra se declar贸 como una tenencia indirecta de los fondos gestionados por Paulson, y la presentaci贸n incluye la cl谩usula est谩ndar en la que Paulson renuncia a la propiedad beneficiaria salvo por cualquier inter茅s pecuniario. La transacci贸n refleja un aumento significativo de la participaci贸n reportada mediante cuentas gestionadas.
John Paulson鞚� 甏�毽� 韼�霌滊ゼ 韱淀暣 2025-08-14鞐� Bausch Health Companies Inc. 欤检嫕 34,721,118欤茧ゼ 欤茧嫻 9雼煬鞐� 旆摑頃橃棳 頃措嫻 韼�霌滌潣 氤搓碃霅� 鞁れ唽鞙犾＜ 歆�攵勳潉 70,755,869欤茧 電橂牳鞀惦媹雼�. Form 4鞐愲姅 鞚� 毵れ垬臧� Paulson鞚� 甏�毽晿電� 韼�霌滌潣 臧勳爲 氤挫湢搿� 鞁犼碃霅橃棃鞙茧┌, 鞝滌稖 靹滊鞐愲姅 Paulson鞚� 旮堨爠鞝� 鞚错暣甏�瓿勲ゼ 鞝滌櫢頃� 頃滌棎靹� 鞁れ唽鞙犼秾鞚� 攵�鞚疙暅雼る姅 響滌 氅挫眳 氍戈惮臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 鞚措矆 瓯半灅電� 甏�毽� 瓿勳爼鞚� 韱淀暣 氤搓碃霅� 歆�攵勳澊 靸侂嫻頌� 歃濌皜頄堨潓鞚� 氤挫棳欷嶋媹雼�.
John Paulson, via des fonds g茅r茅s, a acquis 34 721 118 actions de Bausch Health Companies Inc. 脿 9$ l'action le 14/08/2025, portant la participation b茅n茅ficiaire d茅clar茅e des fonds 脿 70 755 869 actions. Le formulaire 4 indique que l'achat a 茅t茅 d茅clar茅 comme une d茅tention indirecte par les fonds g茅r茅s par Paulson, et le d茅p么t comprend la clause standard par laquelle Paulson d茅cline la qualit茅 de propri茅taire b茅n茅ficiaire, sauf pour tout int茅r锚t p茅cuniaire. La transaction refl猫te une augmentation notable de la participation d茅clar茅e via des comptes g茅r茅s.
John Paulson erwarb am 14.08.2025 眉ber verwaltete Fonds 34.721.118 Aktien der Bausch Health Companies Inc. zu je 9$ und erh枚hte damit das gemeldete wirtschaftliche Eigentum der Fonds auf 70.755.869 Aktien. Das Formular 4 weist aus, dass der Kauf als indirekte Beteiligung der von Paulson verwalteten Fonds gemeldet wurde, und die Einreichung enth盲lt den 眉blichen Haftungsausschluss, wonach Paulson das wirtschaftliche Eigentum au脽er f眉r etwaige pecuni盲re Interessen bestreitet. Die Transaktion stellt eine erhebliche Erh枚hung der gemeldeten Beteiligung 眉ber verwaltete Konten dar.
- Large disclosed purchase: Acquisition of 34,721,118 shares indicates a substantial increase in the Funds' reported stake.
- Material post-transaction ownership: Reported beneficial ownership increased to 70,755,869 shares, showing significant exposure to BHC.
- Transparent reporting: Transaction was reported on a Form 4 with explanatory footnote and standard Rule 16 disclaimer.
- None.
Insights
TL;DR: A large, disclosed purchase by Paulson-managed funds raises the reported stake to 70.8 million shares, a materially larger ownership position.
The acquisition of 34.7 million shares at $9 each meaningfully increases the Funds' reported position in BHC, signaling either conviction at the reported price or portfolio rebalancing. For investors, a reported increase of this magnitude can affect float and perceived insider confidence. The Form 4 lists the ownership as indirect via managed funds rather than direct personal ownership, and the filing includes the customary Rule 16a-1(a)(4) disclaimer about beneficial ownership.
TL;DR: Transaction is clearly disclosed and categorized as indirect; standard ownership disclaimers present.
The Form 4 properly reports the transaction code and classifies the holdings as indirect beneficial ownership by Funds managed by Paulson. The explanatory footnote clarifies the relationship and includes the Rule 16 disclaimer, which is routine. The filing does not indicate any change in director status or a new control claim beyond managerial role and indirect ownership.
John Paulson, tramite fondi gestiti, ha acquisito 34.721.118 azioni di Bausch Health Companies Inc. a 9$ per azione il 08/14/2025, portando la partecipazione beneficiaria dichiarata dei fondi a 70.755.869 azioni. Il Modulo 4 indica che l'acquisto 猫 stato segnalato come detenzione indiretta dai fondi gestiti da Paulson e la comunicazione include la consueta clausola con cui Paulson declina la titolarit脿 beneficiaria, fatta eccezione per eventuali interessi pecuniari. L'operazione rappresenta un consistente aumento della partecipazione riportata tramite conti gestiti.
John Paulson, a trav茅s de fondos administrados, adquiri贸 34.721.118 acciones de Bausch Health Companies Inc. a 9$ por acci贸n el 08/14/2025, elevando la participaci贸n beneficiaria reportada de los fondos a 70.755.869 acciones. El Formulario 4 muestra que la compra se declar贸 como una tenencia indirecta de los fondos gestionados por Paulson, y la presentaci贸n incluye la cl谩usula est谩ndar en la que Paulson renuncia a la propiedad beneficiaria salvo por cualquier inter茅s pecuniario. La transacci贸n refleja un aumento significativo de la participaci贸n reportada mediante cuentas gestionadas.
John Paulson鞚� 甏�毽� 韼�霌滊ゼ 韱淀暣 2025-08-14鞐� Bausch Health Companies Inc. 欤检嫕 34,721,118欤茧ゼ 欤茧嫻 9雼煬鞐� 旆摑頃橃棳 頃措嫻 韼�霌滌潣 氤搓碃霅� 鞁れ唽鞙犾＜ 歆�攵勳潉 70,755,869欤茧 電橂牳鞀惦媹雼�. Form 4鞐愲姅 鞚� 毵れ垬臧� Paulson鞚� 甏�毽晿電� 韼�霌滌潣 臧勳爲 氤挫湢搿� 鞁犼碃霅橃棃鞙茧┌, 鞝滌稖 靹滊鞐愲姅 Paulson鞚� 旮堨爠鞝� 鞚错暣甏�瓿勲ゼ 鞝滌櫢頃� 頃滌棎靹� 鞁れ唽鞙犼秾鞚� 攵�鞚疙暅雼る姅 響滌 氅挫眳 氍戈惮臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 鞚措矆 瓯半灅電� 甏�毽� 瓿勳爼鞚� 韱淀暣 氤搓碃霅� 歆�攵勳澊 靸侂嫻頌� 歃濌皜頄堨潓鞚� 氤挫棳欷嶋媹雼�.
John Paulson, via des fonds g茅r茅s, a acquis 34 721 118 actions de Bausch Health Companies Inc. 脿 9$ l'action le 14/08/2025, portant la participation b茅n茅ficiaire d茅clar茅e des fonds 脿 70 755 869 actions. Le formulaire 4 indique que l'achat a 茅t茅 d茅clar茅 comme une d茅tention indirecte par les fonds g茅r茅s par Paulson, et le d茅p么t comprend la clause standard par laquelle Paulson d茅cline la qualit茅 de propri茅taire b茅n茅ficiaire, sauf pour tout int茅r锚t p茅cuniaire. La transaction refl猫te une augmentation notable de la participation d茅clar茅e via des comptes g茅r茅s.
John Paulson erwarb am 14.08.2025 眉ber verwaltete Fonds 34.721.118 Aktien der Bausch Health Companies Inc. zu je 9$ und erh枚hte damit das gemeldete wirtschaftliche Eigentum der Fonds auf 70.755.869 Aktien. Das Formular 4 weist aus, dass der Kauf als indirekte Beteiligung der von Paulson verwalteten Fonds gemeldet wurde, und die Einreichung enth盲lt den 眉blichen Haftungsausschluss, wonach Paulson das wirtschaftliche Eigentum au脽er f眉r etwaige pecuni盲re Interessen bestreitet. Die Transaktion stellt eine erhebliche Erh枚hung der gemeldeten Beteiligung 眉ber verwaltete Konten dar.
FAQ
What transaction did John Paulson report for BHC on the Form 4?
How many BHC shares do the Paulson-managed funds beneficially own after the transaction?
Is John Paulson shown as a direct owner of the shares in the Form 4?
What was the price per share for the reported BHC acquisition?
Does the filing indicate any change in Paulson's role at BHC?
